CSS
KURA icon

Cubist Systematic Strategies’s Kura Oncology KURA Stock Holding History

Cubist Systematic Strategies’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$611K Buy
+69,040
New +$492K ﹤0.01% 2185
2024
Q4 		– Sell
-45,927
Closed -$897K – 3291
2024
Q3 		$897K Buy
+45,927
New +$931K 0.01% 1899
2024
Q2 		– Sell
-109,161
Closed -$2.33M – 3525
2024
Q1 		$2.33M Buy
109,161
+83,950
+333% +$1.63M 0.01% 1526
2023
Q4 		$363K Buy
+25,211
New +$248K ﹤0.01% 2697
2023
Q2 		– Sell
-53,629
Closed -$656K – 3936
2023
Q1 		$656K Buy
53,629
+49,029
+1,066% +$612K ﹤0.01% 2492
2022
Q4 		$57.1K Sell
4,600
-301,437
-98% -$4.38M ﹤0.01% 3882
2022
Q3 		$4.18M Buy
306,037
+293,469
+2,335% +$4.53M 0.02% 1254
2022
Q2 		$230K Sell
12,568
-4,879
-28% -$70.2K ﹤0.01% 3616
2022
Q1 		$281K Sell
17,447
-43,235
-71% -$624K ﹤0.01% 2876
2021
Q4 		$850K Sell
60,682
-16,420
-21% -$266K 0.01% 2043
2021
Q3 		$1.44M Buy
77,102
+11,271
+17% +$212K 0.02% 1253
2021
Q2 		$1.37M Buy
+65,831
New +$1.63M 0.02% 1352
2021
Q1 		– Sell
-24,075
Closed -$786K – 2904
2020
Q4 		$786K Buy
24,075
+241
+1% +$8.47K 0.01% 1526
2020
Q3 		$730K Buy
23,834
+15,501
+186% +$342K 0.01% 1512
2020
Q2 		$136K Buy
+8,333
New +$120K ﹤0.01% 2138
2020
Q1 		– Sell
-15,684
Closed -$216K – 2303
2019
Q4 		$216K Buy
+15,684
New +$232K ﹤0.01% 2004
2019
Q3 		– Sell
-11,898
Closed -$234K – 2341
2019
Q2 		$234K Buy
+11,898
New +$197K ﹤0.01% 1969

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Cubist Systematic Strategies's KURA Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Kura Oncology (KURA) in Q3 2025: 69,040 shares worth $611K. The stake represents ﹤0.01% of the portfolio and ranks #2185 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in KURA as recently as Q3 2024.

Cubist Systematic Strategies first reported a position in KURA in Q2 2019 and has held it in 17 quarters since. The position peaked at $4.18M in Q3 2022. 200 funds tracked by Wall St. Rank hold KURA as of Q3 2025.

  • Cubist Systematic Strategies held 69,040 shares of Kura Oncology worth $611K as of Q3 2025.
  • Kura Oncology was a new Cubist Systematic Strategies position in Q3 2025.
  • Kura Oncology made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2185 holding.
  • Cubist Systematic Strategies first reported a position in Kura Oncology in Q2 2019 and has held it in 17 quarters since.
  • Cubist Systematic Strategies's Kura Oncology position peaked at $4.18M in Q3 2022.
  • 200 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.